Carlumab
Based on 5 publication(s) in Google Scholar
Carlumab (CNTO 888) is a human anti-CCL2 (chemokine ligand 2) monoclonal antibody. Carlumab binds to human CCL2 and neutralizes its pro-fibrotic activity. Carlumab inhibits tumor growth by reducing macrophage infiltration and decreasing tumor microvessel density. Carlumab can be used in cancer research, such as prostate cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 97.80%
- CAS 番号: 915404-94-3
- 分子量:144.87 kDa
-
保管条件:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
CCL2 |
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized MCP-1/CCL2 Protein, Human (HY-P7237) can bind Carlumab. The EC50 for this effect is 9.459 ng/mL. -
Flow cytometric analysis of 1.5X106 RAW264.7 cells treated with 100ng/mL LPS for 4 hours add 1μg/mL BFA for3 hours with Carlumab (HY-P99188, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃, Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control,cells without incubation with primary antibody were used as the unlabeled control (black).
Product Details
-
CAS 番号 915404-94-3
-
アクセッション番号 P13500
-
別名 CNTO 888
-
分子量 144.87 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
性状
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
純度
97.80%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
輸送条件
Shipping with dry ice.
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
-
J Thorac Oncol
The impact of targeting TRAF2 and NCK-interacting protein kinase (TNIK) on anti-tumor effect and tumor immune environment in c-MYC-high small cell lung cancer. [Abstract]2025 Dec 26:S1556-0864(25)03066-7. PMID: 41456708 -
Adv Sci (Weinh)
Mesenchymal Stem Cell-Derived Extracellular Vesicles Modulate the Course of Peritoneal Inflammation Through Metabolic and Epigenetic Regulation. [Abstract]2025 Nov 26:e08645. PMID: 41293953 -
Commun Biol
Targeting STING to disrupt macrophage-mediated adhesion in encapsulating peritoneal sclerosis. [Abstract]2025 Aug 23;8(1):1266. PMID: 40847090 -
bioRxiv
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women. [Abstract]2024 Oct 21:2024.10.18.616978. PMID: 39484485
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)